Roche 's Genentech buy is the third big acquisition by a drugmaker this year , following Pfizer Inc 's ( PFE.N ) $ 68 billion acquisition of Wyeth ( WYE.N ) and Merck & Co Inc 's ( MRK.N ) $ 41 billion tie-up with Schering Plough Corp ( SGP.N ) .